Bioorganic and Medicinal Chemistry Letters p. 1991 - 1996 (1998)
Update date:2022-08-03
Topics:
Augelli-Szafran, Corinne E.
Jaen, Juan C.
Moreland, David W.
Nelson, Carrie B.
Penvose-Yi, Jan R.
Schwarz, Roy D.
Our interest in the area of m4 muscarinic antagonists has led us to study a series of benzoxazine isoquinolines. One of the most potent and selective compounds of this series is example 1 with an IC50 value of 90.7nM at m4 receptors, and 72-fold (m1), 38-fold (m2), 10-fold (m3), and 82- fold (m5) more selective compared to the other receptors. The synthesis and receptor binding affinity of analogs of 1 are reported.
View MoreShanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
website:http://www.shengmaochem.com
Contact:86-27-82853423, 82819281
Address:Rm 202, A Unit Huaqiao Building No. 2, Lihuangpi Road, Wuhan, China
Shanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
website:http://www.gbxfsilicones.com/
Contact:86-25-68900673
Address:He Country Provincial Fine Chemical Industrial Park of Chaohu city,Anhui province,China
Doi:10.1248/cpb.53.256
(2005)Doi:10.1021/ma0115850
(2002)Doi:10.1016/0223-5234(89)90106-2
(1989)Doi:10.1016/j.tet.2010.05.051
(2010)Doi:10.1002/adsc.201500426
(2015)Doi:10.1139/v69-202
(1969)
